Back

Lakewood-Amedex lists on Nasdaq after $7.5 million private placement

Verifying
  • Lakewood-Amedex listed common stock on Nasdaq and advanced Nu-3 toward Phase 2a development.
  • $7.5 million was raised through a Series C preferred-stock private placement in April 2026.
  • The company reported 72 granted patents and 29 pending applications worldwide.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.